Physician profile
Jane Wey
NPI 1891774592
$1,150.15
in general payments reported to CMS, 2019-2025
7 companies · $70.28 in 2025
The $70.28 reported for 2025 was less than what a typical Surgical Oncology provider received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $126 · 2020: $20.27 · 2021: $228 · 2024: $706 · 2025: $70.28.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $602 · Food and Beverage: $174.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $602.19 |
| Food and Beverage | $173.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $751.41 | 2021-2024 | 1788 |
| Allergan, INC. | $127.67 | 2019-2020 | |
| Karl Storz Endoscopy-America | $79.14 | 2021 | |
| Solventum Corporation | $70.28 | 2025 | Prevena, Activ.A.C., V.A.C.Ulta |
| Kerecis Limited | $56.58 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Endomagnetics LTD | $46.89 | 2024 | Magseed, Magtrace |
| Ethicon US, LLC | $18.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jane Wey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.